Skip to content
Catalyst

PapersPMID:23660094

[Amelioration of inflammatory reaction in patients with severe sepsis with inosine].

Zhonghua wei zhong bing ji jiu yi xue2013The record ↗

  1. Finding, very limited evidencelowersAlanine aminotransferase

What moved

1 findingHow to read these marks →
  • “The lowering of alanine transaminase (ALT), total bilirubin, B-type natriuretic peptide (BNP), oxygenation index was more marked in inosine within 6-hour and after 6-hour groups than those of conventional therapy group (ALT: 42.0 ± 10.8 U/L, 46.0 ± 7.9 U/L vs. 63.0 ± 9.4 U/L, total bilirubin: 16.3 ± 6.7 μmol/L, 18.3 ± 7.3 μmol/L vs. 28.1 ± 8.5 μmol/L, BNP: 322.0 ± 28.7 ng/L, 347.0 ± 31.4 ng/L vs. 428.0 ± 43.2 ng/L, oxygenation index: 210.0 ± 23.8 mm Hg, 198.0 ± 21.4 mm Hg vs. 163.0 ± 15.2 mm Hg, all P<0.05).”
    Study
    RCT
    Dose studied
    inosine 600 mg by intravenous infusion twice daily for 10-14 days or until death or ICU discharge, started within 6 hours or after 6 hours, added to routine treatment
    Population
    Adults with severe sepsis in an intensive care unit, routine treatment in all arms; two inosine arms (started within 6 hours and after 6 hours) against routine treatment alone

Study record

Design
randomised controlled trial
Species
human
Population
severe sepsis patients hospitalized in intensive care unit (ICU) from March 2011 to August 2012
Participants
85
Comparator
no treatment
Duration
not reported
Endpoints measured
11